WAVESRecruiting

Survey on the Current State of Care for Breast Cancer Patients

Gender
Women and men
Age
18 years and older
Trial type
Observational
Line of therapy
all
Phase

What is this trial about?

A breast cancer diagnosis is a profound turning point for those affected—both physically, in terms of the necessary treatment and potential side effects, and mentally, in terms of coming to terms with the disease and undergoing intensive treatment. Open communication between patients and their healthcare providers is therefore of great importance. The goal of the WAVES project is to assess the current state of care for patients with breast cancer through a questionnaire-based survey. Women and men aged 18 and older with breast cancer are eligible to participate in this study.

Detailed description

Breast cancer (mammary carcinoma) is a malignant disease of the breast tissue characterized by the uncontrolled proliferation of breast cells. Regardless of the stage of the disease, those affected must seek medical treatment and usually undergo intensive therapy. This is physically and psychologically taxing, which is why the relationship between the patient and the medical staff plays a central role in this situation. A treatment plan tailored to the individual patient is of great importance. Due to potential side effects, regular discussions should take place between the patient and the doctor to discuss the benefits and drawbacks of the treatment or possible changes to the treatment plan. The COVID-19 pandemic has once again highlighted the importance and challenges of providing adequate and continuous patient care. To identify potential gaps in care and develop improvements, it is crucial to assess the current state of affairs.

The goal of the WAVES project is to analyze the current care situation for patients with breast cancer and to evaluate communication between patients and physicians. This also includes the therapies used, their tolerability, side effects, and concomitant medications. This is based on a questionnaire that is completed once after confirmation of participation. Participants can answer the questions either by mail or electronically. In addition, the treating physicians receive a questionnaire with questions about the current treatment, side effects, communication, and non-personally identifiable data. No new medications or therapies are being investigated as part of this study.

Women and men aged 18 and older with breast cancer are eligible to participate in this study.

Facts

  1. What disease: Breast cancer (mammary carcinoma)
  2. Cancer characteristics: Regardless of the stage of the disease
  3. What the study investigates: Surveys of patients and physicians regarding the treatment of those affected
  4. Study objective: To assess the current state of care and identify potential gaps
  5. How long does the study last: One-time survey
  6. Study details: Questionnaire sent by mail or electronically

Trial sites

1 trial site in Germany is listed.

  • Universitätsklinikum Augsburg

    Stenglinstraße 2, 86156 Augsburg

    Recruiting

This list is compiled to the best of our knowledge but without guarantee: it may be incomplete, and a site's recruitment status can change at any time.

Medical editorial team

  • Dr. med. Sebastian SommerSpecialist in internal medicine with a focus on hematology and oncology
  • PD Dr. med. Matthias FröhlichSpecialist in internal medicine, immunology and emergency medicine

This description is based on the public trial registry (NCT06416293) and was translated into plain language by our medical editorial team. Whether participation is an option for you is a decision you make together with your treating physician.